List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1861 studies with search of: novartis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules
Condition: Meningococcal Disease
Intervention: Biological: Serogroup B meningococcal Vaccine
2 Completed A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Novartis Meningococcal ACWY Conjugate Vaccine
3 Completed A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Congugate Vaccine In Adolescents
Conditions: Meningococcal Meningitis;   Meningococcal Disease
Intervention: Biological: Novartis Meningococcal ACWY Conjugate Vaccine
4 Completed A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults
Conditions: Meningococcal Meningitis;   Meningococcal Disease
Intervention: Biological: Meningococcal ACWY Conjugate Vaccine
5 Completed Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
Condition: Meningococcal Disease
Interventions: Biological: serogroups ACWY meningococcal vaccine;   Biological: Serogroup B meningococcal Vaccine
6 Active, not recruiting B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
Condition: Meningococcal Disease
Intervention: Biological: Meningococcal ACWY Conjugate Vaccine
7 Active, not recruiting A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
Condition: Meningitis, Meningococcal
Intervention: Biological: Meningococcal ACWY Conjugate Vaccine
8 Recruiting Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers
Condition: Meningococcal Infections
Interventions: Biological: MenACWY and MMRV;   Biological: MMRV
9 Recruiting Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers
Condition: Meningococcal Disease
Interventions: Biological: 1a - rMenB+OMV NZ and routine infant vaccinations;   Biological: 1b - rMenB+OMV NZ and routine infant vaccinations;   Biological: 2a - Routine infant vaccinations and rMenB+OMV NZ;   Biological: 2b - rMenB+OMV NZ and routine infant vaccinations;   Biological: 3a - rMenB+OMV NZ and routine infant vaccinations;   Biological: 3b - 1 dose of rMenB+OMV NZ plus routine infant vaccinations;   Biological: 4a- rMenB+OMV NZ and routine infant vaccinations;   Biological: 4b - rMenB+OMV NZ and routine infant vaccinations
10 Active, not recruiting Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
Condition: Meningococcal Infections
Intervention: Biological: MenACWY
11 Active, not recruiting Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1);   Biological: Serogroup B meningococcal Vaccine lot 2 (rMenB Lot 2);   Biological: Serogroup B meningococcal Vaccine lot 3 (rMenB Lot 3);   Biological: Routine vaccination;   Biological: Meningococcal group C
12 Recruiting Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
Condition: Meningococcal Meningitis
Interventions: Biological: MenACWY + Concomitant Vaccination;   Biological: 1 dose MenACWY + Concomitant Vaccination;   Biological: MenC (12 Month) + Concomitant Vaccination (12 Month)
13 Recruiting Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY;   Biological: Concomitants;   Biological: MenACWY - Detailed safety;   Biological: Concomitants - Detailed safety
14 Recruiting Safety and Long-Term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults
Condition: Tick Born Encephalitis
Intervention: Biological: TBE vaccine for adults
15 Completed Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers
Condition: Healthy
Intervention: Drug: Vildagliptin (LAF237)
16 Active, not recruiting Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma
Condition: H1N1 Influenza Virus
Interventions: Biological: H1N1 vaccine high dose;   Biological: H1N1 vaccine low dose
17 Recruiting Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine
Condition: Meningococcal Meningitis
Interventions: Other: Group I;   Other: Group II;   Other: Group III
18 Recruiting Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
Condition: Meningococcal Disease
Intervention: Other: Blood test
19 Recruiting Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults
Condition: Helicobacter Pylori Infection
Interventions: Biological: H.pylori vaccines;   Biological: Placebo Vaccine
20 Completed Efficacy and Safety of FTY720 in De Novo Adult Renal Transplant Recipients
Condition: Renal Transplantation
Intervention: Drug: FTY720

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services